JULIÁN SANZ ORTEGA-rekin lankidetzan egindako argitalpenak (2)

2018

  1. Durable response to first-line nivolumab in a patient with oligometastatic PD-L1 positive nasopharyngeal cancer

    Oral Oncology

2009

  1. Cáncer de riñón hereditario

    Actas Urologicas Espanolas, Vol. 33, Núm. 2, pp. 127-133